CenterBook Partners LP grew its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 58.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 27,338 shares of the industrial products company’s stock after buying an additional 10,039 shares during the quarter. CenterBook Partners LP’s holdings in Xylem were worth $3,723,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Knuff & Co LLC bought a new position in Xylem in the third quarter worth about $27,000. Board of the Pension Protection Fund bought a new position in Xylem in the fourth quarter worth about $27,000. Wexford Capital LP bought a new position in Xylem in the third quarter worth about $27,000. Ramirez Asset Management Inc. raised its stake in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after buying an additional 100 shares in the last quarter. Finally, FWL Investment Management LLC bought a new position in Xylem in the second quarter worth about $43,000. 87.96% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction dated Monday, May 4th. The shares were purchased at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.
Xylem Price Performance
Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same quarter last year, the firm earned $1.03 earnings per share. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Analysts expect that Xylem Inc. will post 5.51 EPS for the current fiscal year.
Xylem announced that its board has approved a share buyback plan on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to reacquire up to 4.8% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.
Xylem Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be issued a dividend of $0.43 per share. The ex-dividend date is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.6%. Xylem’s dividend payout ratio is presently 42.79%.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on XYL. JPMorgan Chase & Co. decreased their price target on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. Robert W. Baird set a $161.00 price target on shares of Xylem in a research note on Wednesday, February 11th. Stifel Nicolaus decreased their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. UBS Group increased their price target on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $130.00 price target (down from $140.00) on shares of Xylem in a research note on Tuesday, March 31st. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.
Check Out Our Latest Report on XYL
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
